XML 48 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Debt (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Feb. 21, 2020
Debt Instrument [Line Items]          
Total long-term debt $ 624,696   $ 624,696    
Long-term debt interest expense          
Total debt interest expense 11,884 $ 11,612 23,539 $ 23,485  
Principal payment on notes       10,730  
9.5% Non-Recourse 2035 Notes          
Debt Instrument [Line Items]          
Principal amount 421,050   421,050   $ 400,000
Less: 5% retained by the Company (21,053)   (21,053)    
Unamortized debt issuance costs (2,741)   (2,741)    
Total long-term debt $ 396,125   $ 396,125    
Long-term debt interest expense          
Interest rate (as a percent) 9.50%   9.50%   9.50%
Percentage of note to be sold         95.00%
Percentage of note to be retained         5.00%
Net principal $ 400,000   $ 400,000    
Estimated fair value 380,000   380,000    
9.0% Non-Recourse 2033 Notes          
Debt Instrument [Line Items]          
Unamortized debt issuance costs (1,131)   (1,131)    
Long-term debt interest expense          
Total debt interest expense $ 1,900 $ 300 $ 3,700 $ 500  
Interest rate (as a percent) 9.00%   9.00%    
3.25% Convertible Senior Notes Due 2023          
Debt Instrument [Line Items]          
Principal amount $ 230,000   $ 230,000    
Unamortized debt issuance costs (1,429)   (1,429)    
Total long-term debt $ 228,571   $ 228,571    
Long-term debt interest expense          
Interest rate (as a percent) 3.25%   3.25%    
Notes fair value $ 210,500   $ 210,500    
TRC          
Long-term debt interest expense          
Percentage of economic interest     85.00%    
Net interest shortfall $ 2,700   $ 7,400    
Percentage of equity interest 85.00%   85.00%    
Net interest shortfall $ 30,700   $ 30,700    
Net principal paydown $ 10,700   $ 10,700    
TRC | Minimum          
Long-term debt interest expense          
Upward tiering royalties (as a percent)     6.50%    
TRC | Maximum          
Long-term debt interest expense          
Upward tiering royalties (as a percent)     10.00%    
TRC | Issuer II Class C Units          
Long-term debt interest expense          
Percentage of economic interest     75.00%    
Theravance Biopharma R&D, Inc.          
Long-term debt interest expense          
Percentage of economic interest     63.75%    
Theravance Biopharma R&D, Inc. | 9.5% Non-Recourse 2035 Notes          
Long-term debt interest expense          
Interest rate (as a percent) 5.00%   5.00%